Showing results (81-90 of 89) with videos related to
Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Research Square|June 9, 2022
Nebulized fusion inhibitory peptide protects cynomolgus macaques from measles virus infectionOlivier Reynard, Claudia Gonzalez, Claire Dumont, et al.Nature Communications|October 28, 2022
Nebulized fusion inhibitory peptide protects cynomolgus macaques from measles virus infectionOlivier Reynard, Claudia Gonzalez, Claire Dumont, et al.Science (New York, N.Y.)|June 27, 2024
A neutralizing antibody prevents postfusion transition of measles virus fusion proteinDawid S Zyla, Roberta Della Marca, Gele Niemeyer, et al.Iscience|April 24, 2023
SARS-CoV-2 awakens ancient retroviral genes and the expression of proinflammatory HERV-W envelope protein in COVID-19 patientsBenjamin Charvet, Joanna Brunel, Justine Pierquin, et al.Cell Reports. Medicine|March 12, 2024
A vaccine targeting antigen-presenting cells through CD40 induces protective immunity against Nipah diseaseYadira Pastor, Olivier Reynard, Mathieu Iampietro, et al.Communications Biology|January 15, 2025
Intranasally administrated fusion-inhibitory lipopeptides block SARS-CoV-2 infection in mice and enable long-term protective immunitySaid Mougari, Valérie Favède, Camilla Predella, et al.Nature Communications|April 6, 2026
Structural and mechanistic basis for antibody neutralization of the measles fusion proteinDawid S Zyla, Roberta Della Marca, Davide Lacarbonara, et al.Medrxiv : the Preprint Server for Health Sciences|July 24, 2020
Antibody responses to SARS-CoV2 are distinct in children with MIS-C compared to adults with COVID-19Stuart P Weisberg, Thomas Connors, Yun Zhu, et al.Nature Immunology|November 6, 2020
Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrumStuart P Weisberg, Thomas J Connors, Yun Zhu, et al.Pageof 9